Non-invasive Assessment of Cerebral Blood Flow and Oxygen Metabolism in Neonates during Hypothermic Cardiopulmonary Bypass: Feasibility and Clinical Implications by Ferradal, Silvina L. et al.
Non-invasive Assessment of
Cerebral Blood Flow and Oxygen
Metabolism in Neonates during
Hypothermic Cardiopulmonary Bypass:
Feasibility and Clinical Implications
The Harvard community has made this
article openly available.  Please share  how
this access benefits you. Your story matters
Citation Ferradal, S. L., K. Yuki, R. Vyas, C. G. Ha, F. Yi, C. Stopp, D.
Wypij, et al. 2017. “Non-invasive Assessment of Cerebral Blood
Flow and Oxygen Metabolism in Neonates during Hypothermic
Cardiopulmonary Bypass: Feasibility and Clinical Implications.”
Scientific Reports 7 (1): 44117. doi:10.1038/srep44117. http://
dx.doi.org/10.1038/srep44117.
Published Version doi:10.1038/srep44117
Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:32072204
Terms of Use This article was downloaded from Harvard University’s DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at http://
nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-
use#LAA
1Scientific RepoRts | 7:44117 | DOI: 10.1038/srep44117
www.nature.com/scientificreports
Non-invasive Assessment of 
Cerebral Blood Flow and Oxygen 
Metabolism in Neonates during 
Hypothermic Cardiopulmonary 
Bypass: Feasibility and Clinical 
Implications
Silvina L. Ferradal1,*, Koichi Yuki2,*, Rutvi Vyas1, Christopher G. Ha1, Francesca Yi1, 
Christian Stopp3, David Wypij3, Henry H. Cheng3, Jane W. Newburger3, Aditya K. Kaza4, 
Maria A. Franceschini5, Barry D. Kussman2,† & P. Ellen Grant1,†
The neonatal brain is extremely vulnerable to injury during periods of hypoxia and/or ischemia. 
Risk of brain injury is increased during neonatal cardiac surgery, where pre-existing hemodynamic 
instability and metabolic abnormalities are combined with long periods of low cerebral blood flow and/
or circulatory arrest. Our understanding of events associated with cerebral hypoxia-ischemia during 
cardiopulmonary bypass (CPB) remains limited, largely due to inadequate tools to quantify cerebral 
oxygen delivery and consumption non-invasively and in real-time. This pilot study aims to evaluate 
cerebral blood flow (CBF) and oxygen metabolism (CMRO2) intraoperatively in neonates by combining 
two novel non-invasive optical techniques: frequency-domain near-infrared spectroscopy (FD-NIRS) 
and diffuse correlation spectroscopy (DCS). CBF and CMRO2 were quantified before, during and after 
deep hypothermic cardiopulmonary bypass (CPB) in nine neonates. Our results show significantly 
decreased CBF and CMRO2 during hypothermic CPB. More interestingly, a change of coupling between 
both variables is observed during deep hypothermic CPB in all subjects. Our results are consistent with 
previous studies using invasive techniques, supporting the concept of FD-NIRS/DCS as a promising 
technology to monitor cerebral physiology in neonates providing the potential for individual 
optimization of surgical management.
Given its critical functions, the brain is the ultimate organ whose outcome must be optimized in any operating 
room or intensive care setting. All surgical and medical management strategies must be designed to prevent or at 
least minimize brain injury. Neonates undergoing cardiac surgery with cardiopulmonary bypass (CPB) are par-
ticularly vulnerable to hypoxic-ischemic brain injury1–3. Since CPB requires periods of reduced systemic flow and/
or circulatory arrest, cerebral hypothermia is routinely used with a primary goal to reduce cerebral oxygen con-
sumption, such that the risk of hypoxic-ischemic brain injury is minimized. Laboratory and human studies have 
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shown that hypothermia produces a significant neuroprotective reduction in cerebral oxygen consumption4,5. 
Despite the fact that hypothermia and new surgical techniques have led to a significant improvement in survival 
rates, infants undergoing cardiac surgery continue to show abnormal long term neurodevelopmental outcomes6. 
To date there is no information to demonstrate that current neuromonitoring methods prevent brain injury and 
improve neurodevelopmental outcomes7–11. Our understanding of perioperative cerebral hypoxia-ischemia in 
neonates undergoing complex cardiac surgery remains limited, primarily due to the lack of adequate tools to 
quantify cerebral oxygen delivery and consumption non-invasively, in real-time, and at the bedside.
Seminal work by Greeley and colleagues showed that cerebral metabolism is exponentially related to tem-
perature during hypothermic CPB in neonates, infants and children12. They also showed that long periods of 
deep hypothermic circulatory arrest (DHCA) alter cerebral metabolism and blood flow after the arrest period 
despite adequate hypothermic suppression of metabolism13. Antegrade regional cerebral perfusion (RCP) has 
been proposed as a better perfusion technique to avoid or minimize duration of circulatory arrest and maximize 
oxygen delivery to the brain14. However, clinical outcomes available so far do not provide strong evidence of the 
superiority of RCP over DHCA15. This has led to a wide variation in practice and the fundamental question of 
whether it is possible to optimize cerebral oxygen delivery to match cerebral oxygen consumption in individual 
patients. Yet, optimizing cerebral oxygen delivery first requires a technique for monitoring cerebral metabolism 
with minimal risk for the patient.
The techniques used by Greeley et al. 25 years ago to measure cerebral metabolism are invasive and/or require 
exposure to radioactive Xenon12,13. Greeley’s methods are also technically challenging to perform in the operat-
ing room, and are not feasible in routine clinical practice. As a result, these experiments have not been repeated. 
Currently, intraoperative brain health is assessed by monitoring oxygenation with continuous-wave near infrared 
spectroscopy (CW-NIRS). CW-NIRS is limited to work as a trend monitor, as it cannot measure absolute concen-
trations of oxy- (HbO2) and deoxy-hemoglobin (HbR). Consequently, it cannot provide absolute cerebral oxygen 
saturation (SO2) but only relative changes (rSO2). This lack of quantification limits the estimation of normative 
values and undermines comparisons between normal and at-risk neonates. Recently, the advanced non-invasive 
optical techniques of frequency-domain near-infrared spectroscopy (FD-NIRS) and diffuse correlation spectros-
copy (DCS) have demonstrated the ability to not only measure absolute cerebral oxygen saturation but also pro-
vide quantitative measures of cerebral blood volume (CBV) and a quantitative index of cerebral perfusion (CBFi), 
enabling a quantitative index of cerebral oxygen consumption (CMRO2i) to be calculated16–19. These advanced 
optical technologies have the potential to provide similar quantitative information regarding brain health as the 
invasive methods of Greeley with the advantages of lower risk to the patient and the same ease of use as current 
commercial NIRS devices.
This pilot study aims to evaluate the ability of FD-NIRS/DCS to quantify intraoperative cerebral blood flow 
and oxygen metabolism non-invasively in neonates. Because of the extreme physiologic manipulations induced 
by changes in perfusion and temperature (CPB, deep hypothermia, and regional cerebral perfusion), neonatal 
cardiac surgery provides an excellent opportunity to evaluate SO2, CBFi and CMRO2i intraoperatively. If clin-
ical translation of these technologies becomes feasible, they hold great promise in monitoring cerebral health 
in real-time, providing the potential for individual optimization of cerebral oxygen delivery to match cerebral 
metabolic demands.
Results
Cardiac diagnosis and CPB parameters for each patient are summarized in Table 1. Nasopharyngeal temperature 
was maintained less than 24 °C in all patients during hypothermic CPB. Brief DHCA was utilized in all subjects. 
Seven patients received RCP following brief DHCA. Two patients had continuous flow CPB instead. A timeline 
of the measurements is shown in Fig. 1 with measurements made at 5 time points (see Methods for a detailed 
description of the measurement protocol).
Table 2 summarizes the physiologic parameters at each time point, including pH and PaCO2 values uncor-
rected for body temperature. Hematocrit (Hct, %) was maintained in the range (27–37) % during CPB.
ID Diagnosis
Flow rate @ CPB1 
(mL/kg/min)
Flow rate @ RCP/
CPB2 (mL/kg/min)
Flow rate @ RW 
(mL/kg/min)
Longest DHCA 
duration (min)
Longest RCP 
duration (min)
Nadir temp. 
on CPB (°C)
1 HLHS 172 39 207 10 87 15.4
2 HLHS 173 24 138 3 57 21.1
3 d-TGA 165 76 156 11 — 18.1
4 d-TGA with aortic  atresia, VSD 119 29 174 4 54 18.7
5 Type B IAA with VSD 173 43 178 10 65 21.1
6 d-TGA 111 104 141 8 — 23.8
7 HLHS 139 40 212 8 72 17.5
8 d-TGA, ASD, VSD,  and hypoplastic arch 119 28 169 20 73 21.3
9 HLHS 126 39 161 8 44 19.8
Table 1.  Cardiac diagnosis and cardiopulmonary bypass parameters. HLHS: hypoplastic left heart 
syndrome; d-TGA: dextro-transposition of great arteries; VSD: ventricular septal defect; IAA: interrupted aortic 
arch; ASD: aortic septal defect; CPB: cardiopulmonary bypass; DHCA: deep hypothermic circulatory arrest; 
RCP: regional cerebral perfusion.
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Cerebral hemodynamics during neonatal cardiac surgery measured by FD-NIRS/DCS. 
Significant changes in cerebral oxygenation and blood flow were found at the different stages of surgery (Fig. 2). 
In particular, SO2, (CaO2 − CvO2), CBFi and CMRO2i showed statistically significant changes with respect to 
baseline (PI stage) during deep hypothermia (shaded regions). After weaning from CPB, SO2, (CaO2 − CvO2), 
CBFi and CMRO2 were not significantly different from baseline. No significant changes were registered in CBV 
and CaO2.
The variability of our measurements was assessed by computing a coefficient of variation (COV). The aver-
age COV for SO2 and CBFi measurements (consisting of 3 repetitions) was 2.4% (SEM = 0.4%) and 10.7% 
(SEM = 0.5%), respectively.
CBFi/CMRO2i coupling. The CBFi/CMRO2i ratio provides an indicator of the coupling between both 
parameters at different stages (Fig. 3). During deep hypothermia, the CBFi/CMRO2i ratio showed a significant 
increase with respect to baseline (p < 0.005), indicating cerebral blood flow in excess of cerebral demand. This 
ratio decreased during rewarming (but remained significantly higher from the baseline) and returned to baseline 
levels after weaning from CPB (PCPB stage).
Relationship between temperature and CMRO2i. Figure 4 shows the temperature dependency of 
CMRO2i during CPB in a temperature range of 16 °C to 35 °C. The relationship can be described by an exponen-
tial function: CMRO2i = 0.066 e0.08T (r2 = 0.57, p = 0.0003). In order to rule out the effect of circulatory arrest, only 
values corresponding to baseline (PI) and early CPB (CPB1) (before circulatory arrest or RCP) were considered 
in the linear regression between temperature and the logarithm of CMRO2i.
Neurological complications. The intraoperative and postoperative course was uneventful in 7/9 subjects 
with no neurological signs or symptoms triggering a postoperative neurological consult or clinical neuroimag-
ing. One neonate (subject ID: 8) had an unexpected decrease in CBFi in the post cardiopulmonary bypass phase 
(lowest observed but within one standard deviation of the group mean). This neonate required a neurological 
consult due to a complicated cardiac surgery, extended bypass and concern for intraoperative hypoperfusion and 
hypoxic ischemic injury. A post-operative research MRI obtained on this subject 13 days after surgery showed 
multiple foci of white matter injury of unclear etiology as a preoperative MRI was not obtained. However intraop-
erative white matter injury due to hypoperfusion cannot be excluded. This neonate was discharged with no focal 
neurological deficit but is too young for neurocognitive testing. Another neonate (subject ID: 4) required ECMO 
immediately after surgery. This neonate also required a neurological consult due to poor cardiac output and need 
for ECMO. Care was eventually withdrawn due to uncorrectable complex congenital heart disease. This neonate 
had high CBFi post induction but was too unstable for post bypass measures.
Discussion
In this pilot study, we used a custom-made FD-NIRS/DCS system to quantify cerebral blood flow and oxygen 
metabolism during neonatal cardiac surgery. While several studies have employed these techniques to monitor 
neonatal cardiac surgical patients preoperatively and/or postoperatively18–21, this is the first report of intraoper-
ative CBFi and CMRO2i measurements in neonates undergoing hypothermic CPB. The patterns observed in our 
measurements are in agreement with previous results obtained with invasive techniques in a similar population12, 
Figure 1. Timeline of intraoperative measurements. 
PI CPB1 RCP/CPB2 RW PCPB
Temperature (°C) 34.2 ± 0.5 20.5 ± 0.8 *** 20.2 ± 0.9 *** 31.3 ± 0.9 34.5 ± 0.4
Hct (%) 42.5 ± 2.6 30.3 ± 1.2 ** 32.0 ± 1.6 ** 36.6 ± 1.9 39.7 ± 2.3
Hb (g/dL) 13.8 ± 0.9 9.8 ± 0.4 ** 10.3 ± 0.5 ** 11.9 ± 0.6 12.9 ± 0.8
SaO2 (%) 91.6 ± 1.7 99.9 ± 0.1 *** 99.8 ± 0.1 *** 99.7 ± 0.1 *** 86.3 ± 6.8
pH 7.36 ± 0.02 7.32 ± 0.02 *** 7.35 ± 0.01 *** 7.43 ± 0.02 7.34 ± 0.04
PaCO2 (mmHg) 43.8 ± 2.7 52.4 ± 7.4 47.8 ± 7.0 38.0 ± 1.5 * 46.1 ± 3.5
PaO2 (mmHg) 57.5 ± 4.1 608.9 ± 7.7 *** 589.4 ± 11.9 *** 600.8 ± 6.1 *** 144.0 ± 45.9
Table 2.  Summary of physiologic parameters (mean ± SEM) at each time point and significance of change 
relative to PI. *Indicates p < 0.05, **indicates p < 0.005, and *** indicates p < 0.0005.
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suggesting that FD-NIRS/DCS is a promising technology to monitor individual cerebral oxygen metabolism and 
hemodynamics during complex neonatal cardiac surgical procedures.
While neurological complications in adult cardiac surgery are most commonly embolic in nature, those in 
pediatric populations are more frequently related to hypoperfusion and hypoxia, supporting the importance of 
Figure 2. Hemodynamic measurements before, during and after CPB across all subjects. Error bars 
represent SEM values. Shaded regions indicate measurements taken during deep hypothermia. Statistical 
significance relative to post-induction (PI) is noted.
Figure 3. Coupling between cerebral blood flow and oxygen consumption during cardiac surgery. Mean NP 
temperature is overlaid at each stage. Note the considerable increase in the CBFi/CMRO2i ratio, or decrease in 
oxygen extraction, during deep hypothermia relative to post-induction (PI). Error bars represent SEM values. 
Shaded regions indicate measurements taken during deep hypothermia.
www.nature.com/scientificreports/
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understanding the balance between cerebral oxygen delivery (provided by CBF) and consumption. Greeley et al. 
assessed these variables by using Xenon-clearance methods and jugular bulb oximetry12,13. In studies conducted 
in neonates and children, CMRO2 decreased exponentially while CBF decreased linearly during hypothermic 
CPB, leading to a relative excess of blood flow, a situation referred to as “luxury perfusion”. Our findings using 
non-invasive optical methods are consistent with these reports. Specifically, we showed a significant decrease 
( >60%) of CMRO2i during hypothermic CPB relative to baseline (Fig. 2), which accompanied an exponential 
decay with temperature (Fig. 4). While CBFi also decreased, it exhibited a more moderate reduction (31%) dur-
ing hypothermia with respect to baseline values (Fig. 2). The variability of our SO2 and CBFi measurements 
(COVSO2 = 2.4% and COVCBFi = 10.7%) is below the physiological changes observed at the different stages, sug-
gesting that our observations are driven by physiological fluctuations.
Our results also show a change of coupling between cerebral blood flow and oxygen consumption (Fig. 3). 
This is illustrated by the CBFi/CMRO2i ratio, or the inverse of oxygen extraction, that exhibits a two fold increase 
of the average ratio during deep hypothermic bypass relative to baseline. Flow/metabolism coupling is a complex 
process influenced by many parameters (temperature, PaCO2, pH, etc.). As body temperature decreases and pH 
increases with hypothermia, in the pH stat strategy CO2 is added to the blood during CPB in order to maintain 
a pH of 7.4 at the patient’s actual body temperature. Thus, the increase in CBFi relative to CMRO2i during deep 
hypothermia could be partially explained by the counteracting effect between temperature and PaCO2, as it has 
been shown that CO2 is a strong cerebral vasodilator during hypothermic CPB and has the potential to disrupt 
cerebral autoregulation22,23. The mechanism and consequences of the change of coupling are still incompletely 
understood. The luxury perfusion is thought to provide an element of cerebral protection and hence positively 
influence neurodevelopmental outcome5. However, the influence of hypothermia and its interaction with other 
variables during CPB is complex. Hypothermia increases the O2 affinity of hemoglobin so that the fraction of 
CMRO2 dependent on dissolved O2 increases at deep hypothermia24. Dissolved O2 can theoretically meet the 
brain O2 requirements if CBF is adequate. An important question for future studies will be to improve our under-
standing of the implications of hypothermia itself and its relationship to physiological variables such as CBF 
and CMRO2 and neurodevelopmental outcomes. A potential approach for studying this question is by studying 
groups of patients with a similar diagnosis undergoing CPB with deep (<22 °C) versus mild-moderate (28–35 °C) 
hypothermia.
Commercial CW-NIRS systems have been previously used to measure cerebral oxygenation in neonates 
undergoing cardiac surgery25,26. As discussed above, CW-NIRS systems only provide relative measurements of 
cerebral oxygenation (rSO2) and are prone to inaccuracies in the high and low ends of the scale27,28.Our prelimi-
nary comparisons between SO2 and rSO2 (as measured by a commercial system Fore-Sight, CAS Medical Systems 
Inc., Branford, CT) show that while both measurements seem to follow a similar trend, rSO2 overestimates cere-
bral oxygen saturation, particularly in the lower ranges (Supplementary Figure 1). A more systematic study with 
a larger sample needs to be performed in order to explain this bias.
SO2 alone does not offer a measure of cerebral perfusion. As discussed by Elwell and colleagues, SO2 belies the 
complexity of the multiple processes determining cerebral oxygen delivery and consumption29. Cerebral blood 
flow velocity measured by TCD is a reliable surrogate of cerebral blood flow in large arteries provided that the 
diameter of the vessel remains constant, an assumption that might not be met during CPB. Moreover, as the TCD 
signal depends on the angle of insonation and is thus operator dependent, it is technically challenging to obtain 
consistent measurements, hindering accurate real-time assessment of cerebral blood flow. DCS is complemen-
tary to TCD as it measures cerebral blood flow in the microvasculature by measuring light intensity fluctua-
tions caused by the movement of red blood cells30,31. While absolute CBFi does not have units of cerebral blood 
flow, it has shown a strong correlation with cerebral blood flow measured by bolus tracking techniques using 
time-domain NIRS in a neonatal pig model32 as well as in preterm neonates33, and with cerebral blood flow meas-
ured by phase-encoded velocity mapping using magnetic resonance imaging in neonates34. Since both DCS and 
FD-NIRS are sensitive to microvasculature underneath the optical sensor, they offer better estimates of CMRO2 
than by combining SO2 NIRS with other modalities like TCD which measure blood velocity in large vessels and 
may not accurately reflect cortical perfusion at the site of the probe.
Figure 4. Effect of temperature on CMRO2i during CPB. 
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This pilot study has several limitations. Because of routine use of a commercial cerebral oximeter and limited 
space on the forehead, we only performed measurements overlying the right frontal cortex. Future studies will 
include additional locations such as parietal and temporal regions in order to account for potential regional vari-
ability of cerebral blood flow and metabolism.
While FD-NIRS and DCS have the ability to perform continuous measurements of SO2 and CBFi, we only 
considered a number of short measurements to simplify the probe design and avoid confounding effects such 
as motion and instrument drift. Future implementations will consider the design of ergonomic probes that can 
be attached to the infant’s head throughout the entire surgery and newer systems with improved stability, thus 
providing continuous measurements of perfusion and oxygenation.
The goal of this pilot study was to test the ability to track major metabolic changes due to extreme physiologic 
manipulations. Despite the small sample size (N = 9), we were able to obtain statistically significant changes at 
different stages of the surgery that are consistent with previous reports from larger studies. However, larger data-
sets will be required to answer subtler questions such as the effect of perfusion techniques (DHCA versus RCP) on 
cerebral blood flow and oxygenation, or metabolic variability associated with specific cardiac defects.
In summary, this pilot study demonstrated the ability to non-invasively track the extreme cerebral metabolic 
changes during neonatal cardiac surgery. Our results are consistent with previous reports from invasive studies 
and support the idea of FD-NIRS/DCS as a promising technology to monitor individual cerebral physiology in 
neonatal patients.
Methods
The study protocol was reviewed and approved by the Boston Children’s Hospital Committee on Clinical 
Investigation. The study method was designed and carried out in accordance with the BCH Committee on 
Clinical Investigation requirements and the regulations that govern human subjects’ research.
Subjects, anesthetic and CPB management. Nine neonates (median gestational age: 39 weeks; median 
weight: 3.1 kg) admitted to the Cardiac Intensive Care Unit at Boston Children’s Hospital were enrolled in the 
study. Parents who agreed to participate were asked to read and sign an informed consent form as approved by 
the BCH Committee on Clinical Investigation. Only neonates undergoing cardiac surgery for congenital heart 
disease within 30 days of birth were considered eligible. Infants with a known or suspected syndrome, craniofacial 
abnormality, sepsis, metabolic disorder, brain malformation, or brain mass lesion were excluded from the study.
All patients underwent palliative or reparative cardiac surgery within the first week of life (median post-natal 
age at surgery: 4 days). Anesthesia consisted of high-dose opioid (fentanyl ~100 mcg/kg) and muscle relaxant, 
supplemented with isoflurane and/or midazolam as tolerated. CPB was non-pulsatile with a target hematocrit 
of 30% at initiation of bypass. Ice was placed around the head and moved aside during NIRS measurements. 
Temperature was monitored in the nasopharynx as a reflection of brain temperature per our routine practice. In 
addition, arterial and venous return temperatures during CPB were recorded. A pH-stat strategy (blood gas man-
agement with temperature correction) was used during core cooling, low-flow hypothermic bypass, and regional 
cerebral perfusion (RCP). Mean duration of cooling was 21 minutes (Fig. 1). CPB parameters are summarized in 
Table 1.
Study protocol. A total of 5 measurements were performed on each patient (Fig. 1). First, a baseline meas-
urement (post-induction; PI) was made under stable conditions following induction of anesthesia, endotracheal 
intubation, and placement of arterial and venous lines, shortly before skin incision. The second measurement 
(CPB1) was performed at the end of core cooling, i.e., when the patient reached the cooling target tempera-
ture (mean ± SD: 21 ± 4 minutes after initiation of CPB). The third measurement was made after 15 minutes of 
RCP (RCP; n = 7; 16 ± 5 minutes after start of RCP) or after an hour of continuous flow bypass (CPB2; n = 2; 
57 ± 10 minutes after onset of CPB). The timing of the third measurement for both the RCP patients and contin-
uous flow patients was similar (~60 minutes after onset of CPB). A fourth measurement (RW) was done when the 
patient was rewarmed to 30 °C (nasopharyngeal temperature) and prior to cardiac ejection. Given the fast dynam-
ics of this stage, some measurements were performed within a broader range of temperatures (27 °C–35 °C). The 
fifth measurement (PCPB) was performed when the patient was stable and ready to leave the OR. In all stages, the 
probe was placed on the right side of the infant’s forehead. A commercial cerebral oximeter was placed on the left 
side of the forehead as part of routine clinical use.
Instrumentation and optical data analysis. The FD-NIRS system (OxiplexTS, ISS Inc., Champaign, IL, 
USA) has two banks of laser diode sources operating at 8 wavelengths (670–830) nm and two photomultiplier 
tube (PMT) detectors. The laser sources are modulated at 110 MHz, and the PMT detectors operate with a mod-
ulation of 110 MHz + 5 kHz for heterodyne detection at 5 kHz. The DCS system has a long coherence length laser 
source operating at 785 nm and four photon-counting avalanche photodiode (APD) detectors. An eight-channel 
correlator is used to convert the detected light at each DCS detector channel into temporal intensity autocorrela-
tion functions over a delay time range of (2 10−7–0.5) seconds.
A custom-made probe arranges FD-NIRS and DCS sources and detectors in a single row, allowing for 
FD-NIRS measurements at four source-detector (SD) distances (1.5, 2.0, 2.5, and 3.0 cm) and DCS measurements 
at a single SD distance (2.0 cm). Fiber bundles are used to couple FD-NIRS sources and detectors. The DCS laser 
is coupled to a multimode optical fiber and diffused at the fiber tip to provide power levels that comply with the 
ANSI standard. Each of the four DCS detectors is coupled to a single mode optical fiber. The four DCS detection 
single-mode fibers are placed at the same SD distance in order to increase signal-to-noise ratio of the detected 
DCS signal.
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For FD-NIRS, absorption (μ a) and scattering (μ s’) of the sampled tissue were estimated from the amplitude 
attenuation and phase shift measured at each wavelength and SD distance using the multi-distance 
frequency-domain method35. Measurements taken on a phantom block with known optical properties were used 
to estimate coupling coefficients between tissue and optical fibers. Absolute oxygenated (HbO2) and deoxygen-
ated (HbR) hemoglobin were derived from the wavelength-dependent absorption coefficients using hemoglobin 
extinction coefficients reported in the literature36 and assuming a water concentration of 75%37. Cerebral oxygen 
saturation was defined as = +SO HbO /(HbO HbR)2 2 2 .
For DCS, each measured intensity autocorrelation function was fit to obtain a cerebral blood flow index (CBFi) 
using the analytical semi-infinite solution to the correlation diffusion equation for a homogenous medium30,38. 
Individual FD-NIRS derived absorption and scattering coefficients at 785 nm were used in the fitting of CBFi 
at each measured time point (Supplementary Figure 2). Note that the DCS technique provides a measure of 
microvascular perfusion by quantifying intensity fluctuations of multiply scattered light due to the movement of 
red blood cells inside the sampled tissue. CBFi, measured in cm2/sec, has been validated as a measure of regional 
cerebral blood flow32–34.
The optical probe was sanitized and inserted into a single use plastic cover. The FD-NIRS/DCS system was kept 
outside the sterile surgical site. FD-NIRS and DCS measurements were repeated three times per surgery time point 
on the infant’s right forehead. For each repetition, the probe was repositioned in a slightly different area to account 
for local inhomogeneities such as hair and superficial large vessels. FD-NIRS/DCS acquisition time was set to 20 sec-
onds and the three repeated measurements were averaged together to obtain a single value at each time point.
We assessed reproducibility of the SO2 and CBFi measurements by calculating a coefficient of variation 
(COV = standard deviation/mean) for each set of three measurements for each every subject included in the 
study.
Measurements of brain metabolism and blood values. An index of the cerebral metabolic rate of 
oxygen (CMRO2i, cm2/s · mL O2/dL) was calculated using Fick’s principle:
= ⋅ −CMRO CBF (CaO CvO ) (1)i2i 2 2
where CaO2 is the oxygen content of arterial blood and CvO2 is the oxygen content of mixed venous blood. The 
oxygen content CxO2 (mL O2/dL), with x = a or v denoting arterial or venous blood, was calculated according to 
the equation:
= . ⋅ ⋅ + . ⋅CxO 1 39 Hb SxO 0 003 PxO (2)2 2 2
where Hb (g/dL) is the hemoglobin concentration in blood, SxO2 (%) is the arterial or venous oxygen saturation 
and PxO2 (mmHg) is the partial pressure of oxygen in arterial blood or mixed venous blood.Venous oxygen sat-
uration, SvO2, was derived from SO2 measured with FD-NIRS and SaO2 obtained from the arterial blood sample 
using the following equation:
= − α βSvO (SO SaO )/ (3)2 2 2
where α + β = 1, and β = 0.75 is the percent contribution of the venous compartment to the SO2 measurement39.
Cerebral blood volume (CBV, mL/100 g) was calculated as
= ⋅ ⋅CBV (HbT MW )/(Hb D ) (4)Hb bt
where HbT (μ Mol) is the total hemoglobin concentration, MWHb (65,400 g/Mol) is the molecular weight of 
hemoglobin, and Dbt (1.05 g/ml) is the brain tissue density. Finally, oxygen extraction was calculated as (CaO2 
− CvO2).
Statistics. All values are given as mean ± standard error of the mean (SEM) unless stated otherwise. Changes 
between baseline (PI) and other time points were tested using a Wilcoxon two-sided signed-rank test. The 
dependency of CMRO2i on brain temperature was tested by linear regression analysis. Pearson correlations were 
used to examine the relationship of CPB flow rate with CBFi and mean arterial pressure (MAP). A p-value < 0.05 
was considered to be statistically significant. In tables and figures, *indicates p < 0.05, **indicates p < 0.005, and 
***indicates p < 0.0005.
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